Text Size
16 studies found for:    breast cancer AND premenopausal | Open Studies | United States

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Condition: Breast Cancer
Intervention: Other: Blood draw and questionnaires
2 Recruiting S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
Conditions: brca1 Mutation Carrier;   brca2 Mutation Carrier;   Breast Cancer
Interventions: Dietary Supplement: cholecalciferol;   Other: placebo
3 Recruiting Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Placebo;   Drug: secoisolariciresinol
4 Recruiting Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer
Conditions: Breast Cancer;   Precancerous Condition
Interventions: Dietary Supplement: Ground Flaxseed;   Other: No Intervention
5 Recruiting Tamoxifen Citrate in Treating Premenopausal Women With Estrogen Receptor-Positive Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: tamoxifen citrate;   Genetic: polymerase chain reaction;   Other: pharmacological study;   Genetic: gene expression analysis;   Other: immunohistochemistry staining method;   Other: pharmacogenomic studies;   Other: matrix-assisted laser desorption/ionization time of flight mass spectrometry;   Genetic: polymorphism analysis;   Procedure: therapeutic conventional surgery;   Genetic: nucleic acid sequencing;   Genetic: protein analysis
6 Recruiting Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Recurrent Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Akt inhibitor MK2206;   Drug: anastrozole;   Drug: goserelin acetate;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis;   Other: pharmacological study
7 Recruiting Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
Conditions: Breast Cancer;   Lymphoma;   Hodgkin's Lymphoma
Intervention: Behavioral: surveys
8 Unknown † Statins and Breast Cancer Biomarkers
Condition: Breast Cancer
Interventions: Drug: Atorvastatin;   Drug: Placebo
9 Recruiting MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk
Condition: Cancer Free Women
Intervention: Behavioral: questionnaire
10 Recruiting Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
Conditions: Breast Cancer;   Fertility
Intervention:
11 Recruiting High-Risk Breast Duct Epithelium
Conditions: Breast Neoplasms;   Healthy
Intervention:
12 Recruiting The Immune System's Response to Young Women's Breast Cancer
Conditions: Breast Cancer;   Breast Cancer and Pregnancy
Intervention:
13 Recruiting Predictors of Ovarian Insufficiency in Young Breast Cancer Patients
Conditions: Breast Cancer;   Ovarian Insufficiency;   Ovarian Failure
Intervention:
14 Recruiting Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Condition: Ductal Breast Carcinoma in Situ
Interventions: Biological: trastuzumab;   Radiation: radiation therapy;   Other: laboratory biomarker analysis
15 Not yet recruiting PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: PD0332991;   Drug: Anastrozole;   Drug: Goserelin
16 Recruiting Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis;   Other: enzyme-linked immunosorbent assay;   Genetic: gene expression analysis;   Drug: systemic chemotherapy;   Drug: tamoxifen citrate;   Drug: aromatase inhibition therapy
To Top

† Indicates status has not been verified in more than two years